Comparison of the incidence of acute kidney injury during treatment with vancomycin in combination with piperacillin–tazobactam or with meropenem
The purpose of this study was to evaluate the observed incidence of acute kidney injury (AKI) in adult patients receiving either piperacillin–tazobactam (PT) and vancomycin or meropenem and vancomycin for at least 48 h. In this retrospective cohort study, we included adult patients with no known ren...
Main Author: | Majed S. Al Yami |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | Journal of Infection and Public Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034117300199 |
Similar Items
-
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
by: Chi-Hao Shao, et al.
Published: (2022-01-01) -
The association of high Vancomycin trough concentration with acute kidney injury during combination therapy of Piperacillin/Tazobactam and Vancomycin
by: Syuichiro Saito, et al.
Published: (2022-03-01) -
Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
by: Kaori Nakatani, et al.
Published: (2022-08-01) -
Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies
by: Abdulmajeed M. Alshehri, et al.
Published: (2022-04-01) -
Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation
by: Dayana Nasr, et al.
Published: (2022-05-01)